Translational Psychiatry· 2012Q1

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

F. Markus Leweke, Daniele Piomelli, Franziska Pahlisch, Daniela Muhl et al.

1,055citations
Q1SCImago
2012year

Short summary

Cannabidiol (CBD) treatment significantly increased serum anandamide levels and improved psychotic symptoms in acute schizophrenia patients, with a superior side-effect profile compared to the antipsychotic amisulpride.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Pharmacology

PharmacologyMedicine